White Pine Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304K Hold
330
0.09% 200
2025
Q4
$355K Hold
330
0.1% 184
2025
Q3
$252K Hold
330
0.07% 211
2025
Q2
$257K Hold
330
0.08% 208
2025
Q1
$273K Hold
330
0.09% 199
2024
Q4
$255K Hold
330
0.09% 199
2024
Q3
$292K Hold
330
0.1% 191
2024
Q2
$299K Buy
+330
New +$264K 0.11% 180

Other funds holding LLY

White Pine Capital's LLY Position: Q1 2026 in Review

White Pine Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 330 shares worth $304K. The position accounts for 0.09% of the portfolio, ranked #200.

White Pine Capital first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $355K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • White Pine Capital held 330 shares of Eli Lilly worth $304K as of Q1 2026.
  • White Pine Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.09% of White Pine Capital's portfolio in Q1 2026, its #200 holding.
  • White Pine Capital first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • White Pine Capital's Eli Lilly position peaked at $355K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.